et al (1999) Comparison of the effects of venlafaxine, desipramine and paroxetine on noradrenalin and methoxamine evoked constriction of the dorsal hand vein. British Journal of Clinical Pharmacology, 48, 345–354.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.
Anderson, I. M. (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. Journal of Affective Disorders, 58, 19–36.
Anderson, I. M.
Nutt, D. J. & Deakin, J. F. W. (2000) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology, 14, 3–20.
Barbui, C. & Hotopf, M. (2001) Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials. British Journal of Psychiatry, 178, 129–144.
Cornwall, P. & Scott, J. (1997) Partial remission in depressive disorders. Acta Psychiatrica Scandinavica, 95, 265–271.
DerSimonian, R. & Laird, N. (1986) Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177–188.
Freemantle, N. & Mason, J. (2000) The choice of antidepressants for depression in primary care. Family Practice, 16, 103–111.
Edwards, G. (1992) Selective serotonin reuptake inhibitors: a modest though welcome advance in the treatment of depression. BMJ, 304, 1644–1645.
Ferrier, N. (1999) Treatment of major depression: is improvement enough?
Journal of Clinical Psychiatry, 60 (suppl. 6), 10–14.
et al (1999) What is the current place of β-blockade in secondary prevention alter myocardial infarction? A systematic overview and meta regression analysis. BMJ, 318, 1730–1737.
Anderson, I. M. & Young, P. (2000) Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis. British Journal of Psychiatry, 177, 292–302.
Geddes, J. R.
et al (2001) SSRIs versus alternative antidepressants for depressive disorders. Cochrane Library, issue I. Oxford: Update Software.
Gross, G. & Huber, G. (1999) How far are newer antidepressants an advance compared with classical antidepressants?
Neurology, Psychiatry and Brain Research, 7, 79–86.
Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology. Revised DHEW Pub. (ADM). Rockville, MD: National Institute for Mental Health.
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.
Delgado, P. & Charney, D. (1996) The revised monoamine theory of depression: a modulatory role of monoamines, based on new findings from monomaine depletion experiments in humans. Pharmacopsychiatry, 29, 2–11.
Holliday, S. M. & Benfield, P. (1995) Venlafaxine. A review of its pharmacology and therapeutic potential in depression. Drugs, 49, 280–294.
Kelsey, J. (1996) Dose–response relationship with venlafaxine. Journal of Clinical Psychopharmacology, 16 (suppl. 2), 21S–26S.
Montgomery, S. A. & Åsberg, M. (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389.
Murray, C. & Lopez, A. (1997) Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet, 349, 1436–1442.
et al (1991) A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Archives of General Psychiatry, 48, 303–307.
et al (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. Journal of Pharmacological Experimental Therapies, 283, 1305–1322.
et al (1998) A randomised, placebo-controlled, dose–response trial of venlafaxine hydrochloride in the treatment of major depression. Clinical Psychiatry, 59, 116–122.
Jennings, A. L.
et al (1992) Combination treatment of noradrenalin and serotonin reuptake inhibitors in resistant depression. British Journal of Psychiatry, 161, 562–565.
Spiegelhalter, D. & Thomas, A. (1995) Bayesian approaches to random-effects meta-analysis: acomparative study. Statistics in Medicine, 14, 2685–2699.
Stewart, L. A. & Parmar, M. K. B. (1996) Bias in the analysis and reporting of r andomized controlled trials. International Journal of Technology Assessment in Health Care, 12, 264–275.
et al (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. European Journal of Pharmacology, 340, 249–258.
Thase, M. E.
Entsuah, A. R. & Rudolph, R. L. (2001) Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. British Journal of Psychiatry, 178, 234–241.